Skip to main content

MoneyWorks4Me

Cipla - Quaterly Results

28 Oct 2026 Evaluate
The revenue declined to Rs. 50674.20 millions for the quarter ended September 2026 as compared to Rs. 52257.20 millions during the corresponding quarter last year.The Net Profit of the company slipped to Rs. 7870.30 millions from Rs. 12105.30 millions, a decline of -34.98% on QoQ basis.A decline of 12576.40 millions was observed in the OP in the quarter ended September 2026 from 17772.90 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202609 202509 % Var 202609 202509 % Var 202603 202503 % Var
Sales 50674.20 52257.20 -3.03 101451.00 102718.90 -1.23 189799.50 190448.50 -0.34
Other Income 1475.60 2546.60 -42.06 3903.10 5257.30 -25.76 11226.50 9847.20 14.01
PBIDT 12576.40 17772.90 -29.24 25863.30 36728.10 -29.58 55890.40 67631.60 -17.36
Interest 59.20 26.50 123.40 116.00 85.30 35.99 193.00 151.10 27.73
PBDT 12517.20 17746.40 -29.47 25747.30 36642.80 -29.73 53253.70 70427.10 -24.38
Depreciation 1892.90 1413.00 33.96 3586.80 2869.90 24.98 6894.30 5738.90 20.13
PBT 10624.30 16333.40 -34.95 22160.50 33772.90 -34.38 46359.40 64688.20 -28.33
TAX 2754.00 4228.10 -34.86 5668.60 8636.30 -34.36 11207.60 13111.70 -14.52
Deferred Tax -84.20 105.90 -179.51 -248.50 -46.30 436.72 188.60 -491.50 -138.37
PAT 7870.30 12105.30 -34.98 16491.90 25136.60 -34.39 35151.80 51576.50 -31.85
Equity 1615.70 1615.50 0.01 1615.70 1615.50 0.01 1615.60 1615.20 0.02
PBIDTM(%) 24.82 34.01 -27.03 25.49 35.76 -28.70 29.45 35.51 -17.08
Peers
Company Name CMP
Sun Pharma. Inds. 1758.00
Dr. Reddys Labs. 1335.40
Cipla 1360.00
Lupin 1971.00
Zydus Lifesciences 1172.00
View more..